This patent teaches how to expand autologous or allogeneic islet stem cells and to generate from them islets useful for the treatment of diabetes. The culture techniques disclosed involve cytokine, matrix and antibody cocktails. This invention may be useful in conjunction with the various embryonic stem cell technologies that are currently being studied.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.